Paradoxical Effect of Obesity on Survival Outcomes in Prostate Cancer Patients Receiving Enzalutamide and Abiraterone

<i>Background and Objectives</i>: Overweight and obesity is defined as a Body Mass Index (BMI) of 25.0–29.9 kg/m² and ≥30.0 kg/m². The prognostic significance of obesity in metastatic prostate cancer is still unclear, especially between the castration-sensitive (CSPC) and castr...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bahattin Engin Kaya, Mehmet Zahid Koçak, Oğuzhan Yıldız, Talat Aykut, Ali Fuat Gürbüz, Ömer Genç, Melek Karakurt Eryılmaz, Murat Araz, Mehmet Artaç
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-01-01
coleção:	Medicina
Assuntos:	body mass index obesity paradox androgen receptor inhibitors castration-resistant prostate cancer castration-sensitive prostate cancer survival outcomes
Acesso em linha:	https://www.mdpi.com/1648-9144/62/1/202
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!